Effects of pulmonary artery perfusion versus no pulmonary perfusion on the secondary outcomes*
| p Value | ||
|---|---|---|
| Oral tracheal intubation time † | ||
| Oxygenated blood vs no pulmonary perfusion | 0.47 | |
| HTK vs no pulmonary perfusion | 0.10 | |
| Oxygenated blood vs HTK solution | 0.23 | |
| Days alive outside ICU † | ||
| Oxygenated blood vs no pulmonary perfusion | 0.42 | |
| HTK vs no pulmonary perfusion | 0.61 | |
| Oxygenated blood vs HTK solution | 0.92 | |
| Days alive outside the hospital † | ||
| Oxygenated blood vs no pulmonary perfusion | 0.86 | |
| HTK vs no pulmonary perfusion | 0.99 | |
| Oxygenated blood vs HTK solution | 0.97 | |
| OR (95% CI) | p Value | |
| Death at 90 days ‡ | ||
| Oxygenated blood vs no pulmonary perfusion | 0.69 (0.09 to 3.10) | 0.98 |
| HTK vs no pulmonary perfusion | 0.78 (0.01 to 65.37) | 1.00 |
| Oxygenated blood vs HTK solution | 0.47 (0.01 to 9.33) | 0.96 |
| Patients with one or more serious adverse events ‡ | ||
| Oxygenated blood vs no pulmonary perfusion | 0.79 (0.19 to 3.30) | 0.75 |
| HTK vs no pulmonary perfusion | 0.61 (0.13 to 2.85) | 0.53 |
| Oxygenated blood vs HTK solution | 1.33 (0.27 to 6.53) | 0.73 |
*Analysis of the intention-to-treat population.
†Van Elteren test.
‡Exact logistic regression adjusted for stratification variable.
HTK, histidine-tryptophan-ketoglutarate; ICU, intensive care unit; ITT, intension to treat.